Skip to main content
OpenTrials
Completed

NCT Number: NCT00660712

Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Adana, Turkey (Türkiye)

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients previously or currently diagnosed with bipolar disorder
  • Patients (or any of their relatives) who give a written informed consent.

Exclusion criteria

  • Patients who were previously included in this study.

Treatment and study plan

Primary outcomes

  1. Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Secondary outcomes

  1. Evaluation of the time period that elapsed since the diagnosis of bipolar disorder

  2. Evaluation of co-morbid psychiatric diseases

  3. Identification of treatment modalities selected according to the disease phase

  4. Identification of the number of first degree relatives diagnosed with bipolar disorder

  5. Evaluation of the relationship between patient and disease characteristics

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Important dates

Study start
2008
Study completion
2009
First posted
Apr 17, 2008
Registry last updated
May 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.